Follow The Filings

PNC PNC

Financials, filed as PNC FINL SVCS GROUP INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 2

  • 3 Owners
  • #223
  • Max 3.2%
  • Master 0.01%
  • $45M
  • 2 reduce

In 2026 Q3 David Katz and Kentucky Trust trimmed PNC.

Who owns this now

Largest portfolio weights among holders, up to 3.2% (David Katz, Matrix Asset Advisors). Not free-float ownership.

  1. David Katz Reduce 3.2%
  2. Kentucky Trust Co. Reduce 1.9%
  3. Murphy Pohlad 0.92%

Who owns PNC

Sorted by value, long equity only, as of 2026 Q3.

History
David Katz, Matrix Asset Advisors 3.2%, was 3.8% Reduce −8.1% 173,623 $39M History
Kentucky Trust Co., Kentucky Trust 1.9%, was 2.0% Reduce −0.1% 17,177 $3.8M History
Murphy Pohlad, Murphy Pohlad Asset Management 0.92% Hold 11,863 $2.6M History

3 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by PNC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PNC insider trades
  • $4,008 bought by 1 insider
  • $27.2M sold by 9 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Stacy M. Juchno Executive Vice President
    Sale
    $858K 3,354 shares at $255.84 15% of stake
    Traded Aug 13 Filed Aug 14
    ↗
  2. Guild Deborah Executive Vice President
    Sale
    $303K 1,200 shares at $252.20 3.2% of stake
    Traded Jul 22 Filed Jul 24
    ↗
  3. Michael Duane Thomas Executive Vice President
    Sale
    $357K 1,500 shares at $238.14 23% of stake
    Traded Jun 12 Filed Jun 16
    ↗
  4. Alexander E. C. Overstrom Executive Vice President
    Sale
    $342K 1,500 shares at $227.97 7.1% of stake
    Traded Jun 8 Filed Jun 10
    ↗
  5. Stephanie Novosel Executive Vice President
    Sale
    $412K 1,800 shares at $228.73 37% of stake
    Traded Jun 5 Filed Jun 8
    ↗
  6. Andrew T Feldstein Director
    Sale
    $9.9M 45,000 shares at $220.57 81% of stake
    Traded May 26 Filed May 28
    ↗
  7. Linda R Medler Director
    Buy
    $4,008 20 shares at $200.38 New stake
    Traded Mar 9 Filed Mar 11
    ↗
  8. William S Demchak CEO
    Sale
    $11.5M 50,000 shares at $230.88 8.3% of stake
    Traded Feb 20 Filed Feb 24
    ↗
  9. Richard Kevin Bynum Executive Vice President
    Sale
    $1.7M 7,407 shares at $230.98 79% of stake
    Traded Feb 17 Filed Feb 18
    ↗
  10. Alexander E. C. Overstrom Executive Vice President
    Sale
    $585K 2,500 shares at $233.91 11% of stake
    Traded Feb 18 Filed Feb 18
    ↗
  11. Louis Robert Cestello Executive Vice President
    Sale
    $1M 4,279 shares at $234.01 19% of stake
    Traded Feb 18 Filed Feb 18
    ↗
  12. Michael Duane Thomas Executive Vice President
    Sale
    $184K 1,000 shares at $183.57 15% of stake
    Traded Nov 4, 2025 Filed Nov 6, 2025
    ↗
  13. Guild Deborah Executive Vice President
    Sale
    $202K 1,080 shares at $186.97 3.8% of stake
    Traded Oct 24, 2025 Filed Oct 28, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 49 share withholdings for taxes, 38 stock grants, 3 gifts, and 1 other transaction.

Congress

7 members of Congress traded PNC in the last three years: 4 buys and 10 sales. 12 members listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Sell $50K–$100K Mar 27 filed Jul 21
  2. Shelley Moore Capito R-WVSpouse Buy $1K–$15K Mar 12 filed Apr 4
  3. Julia Letlow R-LA-5 Buy $1K–$15K Oct 23, 2024 filed Jan 13
  4. Julie Johnson D-TX-32Joint Sell $1K–$15K Oct 21, 2025 filed Nov 14, 2025
  5. Val T. Hoyle D-OR-4Spouse Sell $1K–$15K Sep 23, 2025 filed Oct 10, 2025
  6. Val T. Hoyle D-OR-4Spouse Buy $1K–$15K Oct 29, 2024 filed Sep 12, 2025

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
8-K 8.01,9.01 Filing Doc
424B2 Filing Doc
424B5 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
424B2 Filing Doc
424B5 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 7 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $561.58B $560.04B $573.57B
Total equity $51.1B $54.42B $60.58B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $10.11B $7.88B $4.38B
Cash from investing -$6.38B -$3.23B -$15.62B
Cash from financing -$3.85B -$9.12B $4.7B
Net change in cash -$0.122B -$4.47B -$6.54B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.